Prenatal antiepileptic exposure associates with neonatal DNA methylation differences

• Authors: Alicia K Smith, Emory University; Karen N Conneely, Emory University; D. Jeffrey Newport, Emory University; Varun Kilaru, Emory University; James W. Schroeder, Emory University; Page B. Pennell, Harvard Medical School; Bettina T. Knight, Emory University; Joseph F Cubells, Emory University; Zachary N. Stowe, University of Arkansas for Medical Sciences; Patricia Brennan, Emory University
• Journal Title: Epigenetics
• Volume: Volume 7, Number 5
• Publisher: Landes Bioscience | 2012-05-01, Pages 458-463
• Type of Work: Article | Post-print: After Peer Review
• Publisher DOI: http://doi.org/10.4161/epi.19617
• Subjects: Biology, Genetics
• Keywords: Antiepileptic drugs (AEDs); DNA Methylation; epigenetic; HumanMethylation27 BeadChip; lamotrigine; neonatal; pregnancy

Abstract

Antiepileptic drugs (AEDs) are used to treat a variety of neuropsychiatric illnesses commonly encountered in women during their reproductive years, including epilepsy and bipolar disorder. Despite their widespread use, the impact of prenatal exposure on fetal development remains obscure. To evaluate whether AEDs taken by pregnant mothers influence DNA methylation patterns in their neonates, DNA was extracted from the umbilical cord blood of 201 neonates whose mothers were treated for neuropsychiatric illness during pregnancy and interrogated across 27,578 CpG sites using the Illumina HumanMethylation27 BeadChip. The association of each methylation value with the cumulative duration of prenatal AED exposure was examined using a linear mixed model. The average methylation level across all CpG sites was calculated for each subject, and this global methylation measure was evaluated similarly. Neonates with a longer duration of AED exposure in pregnancy showed a decrease in average global methylation (p = 0.0045). Further, DNA methylation of CpG sites in 14 genes significantly decreased with the duration of prenatal AED exposure even after adjusting for multiple comparisons (FDR < 0.05). For a small subset (n = 19) of these neonates, a second tissue, placenta, was available in addition to cord blood. Methylation of 3 of these 14 CpG sites was also significantly decreased in placental tissue. These novel data suggest decreased DNA methylation in neonates of mothers who took AEDs during pregnancy. The long-term stability and potential impact of these changes warrant further attention, and caution may be warranted before prescribing AEDs to pregnant women.